Glioblastoma: all 1,951 studies
Page 2 of 20. Open to participants first (457), then studies with results posted, then the rest; newest registration first within each.
- Imaging Acetadote Metabolism in GlioblastomaRecruitingNCT07387666Early Phase 1
- Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair DeficiencyNot yet recruitingNCT07385846Phase 1
- Intraoperative Ultrasound for Brain Tumor Surgery Enhanced by AINot yet recruitingNCT07376304Phase 3
- Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)RecruitingNCT07375992Not applicable
- Limited Target Volume Radiotherapy After Glioblastoma SurgeryNot yet recruitingNCT07368283Not applicable
- Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended UseNot yet recruitingNCT07366892
- Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed GlioblastomaNot yet recruitingNCT07365280Phase 2
- MRinRT: Swansea University and SWWCC Collaboration Study.Not yet recruitingNCT07365124
- Effect of Salovum® on Pressure, Oxygen and Inflammation in GlioblastomaRecruitingNCT07364786Phase 2
- Irinotecan-ChemoSeed in Surgically Resectable GlioblastomaRecruitingNCT07356973Phase 2
- Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent GlioblastomaNot yet recruitingNCT07349693Phase 2/3
- Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade GliomaRecruitingNCT07346144Phase 1/2
- Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated GlioblastomaRecruitingNCT07343986Phase 1
- Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIRecruitingNCT07326566Phase 2
- GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 AstrocytomaRecruitingNCT07301268Phase 2
- A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent GlioblastomaRecruitingNCT07297212Phase 2
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
- Vortioxetine for Newly Diagnosed GlioblastomaRecruitingNCT07284628Phase 2
- Senicapoc and Perampanel for Newly Diagnosed GlioblastomaRecruitingNCT07284069Early Phase 1
- Assessment of Early Post-operative Nuclear Imaging in Neurosurgery: a Safety and Feasibility Study in Patients Operated for GlioblastomaRecruitingNCT07274397Not applicable
- A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain MetastasesRecruitingNCT07268053Early Phase 1
- Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 TrialRecruitingNCT07263438Phase 2
- A Study of DEG6498 in Participants With Solid TumorsRecruitingNCT07244835Phase 1
- Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent GlioblastomaNot yet recruitingNCT07244666Early Phase 1
- Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed GlioblastomaRecruitingNCT07225621Phase 2
- A Study of 177Lu-PSMA-617 in People With GliomasRecruitingNCT07223034Phase 1
- Phase I Trial of pH Resections of GBM at VANot yet recruitingNCT07218367Phase 1
- Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM)Not yet recruitingNCT07211841Not applicable
- Clinical and Treatment Determinant of Prognosis in GlioblastomaNot yet recruitingNCT07197086
- Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CareRecruitingNCT07195591Phase 3
- Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced SpreadRecruitingNCT07193654Phase 2
- B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory GlioblastomaRecruitingNCT07193628Phase 1
- A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM PatientsRecruitingNCT07185880Phase 1/2
- DLL3 CAR-T Therapy Targeting Brain TumorsNot yet recruitingNCT07180927Phase 1/2
- Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard ChemotherapyRecruitingNCT07179328Phase 1
- A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and ProgressionRecruitingNCT07173829
- A Multicenter, Prospective Study for Glioblastoma PatientsNot yet recruitingNCT07162324
- Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent GlioblastomaRecruitingNCT07145112Phase 1
- Clinical Study of Oncolytic Virus in GlioblastomaRecruitingNCT07145047Phase 1/2
- Allogeneic γδT Cells in GlioblastomaRecruitingNCT07144735Not applicable
- A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed GlioblastomaRecruitingNCT07143812Phase 1
- Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic BrachytherapyRecruitingNCT07141732Phase 1
- Phase 2 Clinical Trial of KH617Not yet recruitingNCT07138001Phase 2
- A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.RecruitingNCT07134842Phase 1
- Sonodynamic-Chemoradiotherapy Integration in GlioblastomaEnrolling by invitationNCT07130149Phase 2
- Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRIRecruitingNCT07121842Not applicable
- Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.RecruitingNCT07119294Not applicable
- Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)RecruitingNCT07111195
- Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent GlioblastomaRecruitingNCT07100730Phase 3
- A Study of VRT106 for Injection in Patients With Recurrent/Progressive GlioblastomaRecruitingNCT07093814Phase 1/2
- Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With GlioblastomaRecruitingNCT07091864Not applicable
- A Study for Cerebral Open Flow MicroperfusionNot yet recruitingNCT07089758Not applicable
- ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG TrialRecruitingNCT07089641Phase 1
- Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent GlioblastomaRecruitingNCT07076472Early Phase 1
- A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST TrialRecruitingNCT07074756Not applicable
- Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell CarcinomaRecruitingNCT07067905Early Phase 1
- The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From BevacizumabRecruitingNCT07052877
- A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed GlioblastomaNot yet recruitingNCT07047066Phase 2
- Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.Not yet recruitingNCT07029100Not applicable
- Anterior Temporal Lobectomy in Temporal GlioblastomaRecruitingNCT07021339Phase 3
- A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 GliomasRecruitingNCT07003542Phase 2
- Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed GlioblastomaRecruitingNCT06991101Phase 2
- FearLess in NeuroOncologyRecruitingNCT06989086Not applicable
- Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) ProgressionRecruitingNCT06975332Not applicable
- Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational StudyRecruitingNCT06954636
- IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)Not yet recruitingNCT06946680Phase 1
- Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow FluorescenceNot yet recruitingNCT06939400
- Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term ProgressionRecruitingNCT06936046Phase 2
- Study of ABBV-637 or ABBV-155 With ERAS-801 for People With GlioblastomaRecruitingNCT06934889Phase 1
- Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral TumorNot yet recruitingNCT06929819Not applicable
- Early Phase Study of KESONOTIDE™in Participants With Solid TumoursRecruitingNCT06926075Phase 1/2
- TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)RecruitingNCT06924099
- CUE-102 in Recurrent GlioblastomaRecruitingNCT06917885Phase 1
- A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid TumorsRecruitingNCT06914128Phase 1/2
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent GlioblastomaRecruitingNCT06910306Not applicable
- Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid TumorsRecruitingNCT06902350Phase 1
- Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade GliomaEnrolling by invitationNCT06896110Phase 1
- Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High SignatureRecruitingNCT06894225Phase 2
- A Supportive Group Intervention for Caregivers to Patients Diagnosed With a GlioblastomaNot yet recruitingNCT06869577Not applicable
- Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaRecruitingNCT06860594Phase 1
- The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of GlioblastomaRecruitingNCT06850766Not applicable
- CSF Proteomic Characterization of GlioblastomasNot yet recruitingNCT06845020
- Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized TrialRecruitingNCT06835803Phase 2
- Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed GlioblastomaRecruitingNCT06831526Early Phase 1
- GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive GlioblastomaRecruitingNCT06815432Phase 1
- Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant AstrocytomaRecruitingNCT06815029Phase 1
- Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsRecruitingNCT06814496Phase 1/2
- Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossRecruitingNCT06810544Phase 1/2
- DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)RecruitingNCT06805305Phase 2
- Pharmacoscopy for Patients With Refractory Primary Brain TumorsRecruitingNCT06804655Phase 2
- Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients With Brain Lesions.RecruitingNCT06797661Not applicable
- Drug Response Testing and Repurposing Using Glioblastoma OrganoidRecruitingNCT06782984
- Patient's Derived Organoids for Drug Screening in GlioblastomaNot yet recruitingNCT06781372Not applicable
- Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After SurgeryNot yet recruitingNCT06780592Phase 2
- BC008-1A Injection for Recurrent CNS WHO G4 GliomaRecruitingNCT06773481Phase 1
- Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in GlioblastomaNot yet recruitingNCT06764537Not applicable
- Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma PatientsRecruitingNCT06757153Early Phase 1
- Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for GlioblastomaNot yet recruitingNCT06749925Phase 3
- Hypofractionated RadiotherapyRecruitingNCT06740955Not applicable
- Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target VolumeRecruitingNCT06719440Not applicable